Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07658547 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of AI Chatbots for Mental Health

Study acronym: NUKI-PSY
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Aug 2026 → Oct 2026
See other at-risk trials from Medizinische Hochschule Brandenburg Theodor Fontane

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion pushed from Aug 2026 to Oct 2026
    • Start date changed from estimate of Jun 2026 to Jul 31, 2026
    • Eligibility criteria expanded, about 2 words
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to learn how patients with mental disorders use, perceive, and evaluate generative artificial intelligence (AI) chatbots for mental health-related purposes. The study aims to investigate usage patterns, expectations, experiences, perceived benefits, barriers, and concerns regarding AI chatbots among adults receiving psychiatric or psychotherapeutic treatment. The main questions it aims to answer are: * "How do patients with mental disorders use generative AI chatbots in the context of their mental health?" * "What expectations, attitudes, and experiences do patients have regarding AI chatbots for mental health support?" Participants will: * Provide electronic informed consent before participation. * Complete a one-time anonymous online survey lasting approximately 8 to 10 minutes. * Answer questions about sociodemographic characteristics, psychiatric diagnoses, psychological distress, and digital device use. * Report their expectations regarding AI chatbots for mental health support. * Provide information about AI chatbot use, including frequency, duration, applications used, and purposes of use. * Answer questions regarding satisfaction, trust, privacy concerns, perceived problems, and potential future integration of AI chatbots into mental health care. * Optionally provide qualitative comments and suggestions in open-text fields. * Optionally participate in semi-structured qualitative interviews to explore their experiences, attitudes, and perceptions regarding AI chatbots in greater depth. There is no intervention, randomization, control group, or comparison arm in this study. The study follows a prospective cross-sectional mixed-methods design using quantitative survey data, qualitative free-text responses, and semi-structured interviews.
Trial Details
NCT Number NCT07658547
Lead Sponsor Medizinische Hochschule Brandenburg Theodor Fontane
Conditions
(from sponsor)
Severe Mental Illness
Related terms Mental Disorders
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov